PYPD Latest Press Releases

-- October 28, 2026 --

PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix Based Product Candidate for the Treatment of Diabetic Foot Infections Globe Newswire 8:00 AM

-- October 21, 2026 --

PolyPid to Present D-PLEX100 Microbiology Data at IDWeek 2026 Globe Newswire 8:00 AM

-- October 15, 2026 --

PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026 Globe Newswire 8:30 AM

-- October 1, 2026 --

European Medicines Agency Validates PolyPid's Marketing Authorization Application for D-PLEX100 Globe Newswire 9:15 AM

PolyPid Regains European Commercialization Rights for D-PLEX100, Expanding Global Commercialization Opportunities Globe Newswire 8:56 AM

-- September 15, 2026 --

PolyPid Announces Participation in Upcoming Fall Investor Conferences Globe Newswire 8:30 AM

-- August 12, 2026 --

PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results Globe Newswire 7:30 AM

-- July 30, 2026 --

PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026 Globe Newswire 8:00 AM

-- July 29, 2026 --

PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX100 Globe Newswire 8:30 AM

-- July 21, 2026 --

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX100 in the U.S. and Canada Globe Newswire 7:30 AM

-- June 1, 2026 --

PolyPid Completes New Drug Application Submission to FDA for D-PLEX100 Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes